Aerie Pharmaceuticals, Inc. AERI
Set alert
15.25 +15.25 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 0
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -13.86
- Beta
- -0.06
- Short ratio
- 1.91
- Inst. own
- 102.99%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2022
- 50-d avg
- 15.19
- 200-d avg
- 10.24
- 1y target
- 15.35
Analyst view
Consensus: hold
Hold
Price target (mean) 15.35 +0.7% upside
Now 15.25
- Target (low)
- 6.00
- Target (mean)
- 15.35
- Target (high)
- 25.00
Ratings (0m) 10 9 buy · 1 hold · 0 sell
- Strong buy3
- Buy6
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 8
- 2 months ago 8
- 3 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.43 | -0.57 – -0.33 | 1.09 | -139.4% | 38.10M | +16.6% | 7 |
| Next quarter | -0.32 | -0.32 – -0.32 | -0.66 | +51.5% | 38.87M | +30.3% | 1 |
| Current year | -1.84 | -2.02 – -1.65 | -0.97 | -89.7% | 137.29M | +22.4% | 5 |
| Next year | -1.10 | -1.48 – -0.54 | -1.84 | +40.2% | 175.44M | +27.8% | 6 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 29, 2022 | Citigroup | Downgrade | Buy | Neutral |
| Aug 24, 2022 | Truist Securities | Downgrade | Buy | Hold |
| Aug 24, 2022 | HC Wainwright & Co. | Downgrade | Buy | Neutral |
| Aug 23, 2022 | Stifel | Downgrade | Buy | Hold |
| Aug 23, 2022 | Needham | Downgrade | Buy | Hold |
| Aug 23, 2022 | Cantor Fitzgerald | Downgrade | Overweight | Neutral |
| May 9, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Feb 25, 2022 | Needham | Maintained | — | Buy |
| Nov 5, 2021 | Needham | Maintained | — | Buy |
| Aug 5, 2021 | Needham | Maintained | — | Buy |
| Nov 9, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Oct 19, 2020 | B of A Securities | Downgrade | Neutral | Underperform |
| Sep 8, 2020 | Guggenheim | Initiated | — | Buy |
| Aug 10, 2020 | Citigroup | Maintained | — | Buy |
| Aug 7, 2020 | Needham | Maintained | — | Buy |
| Jun 1, 2020 | Oppenheimer | Maintained | — | Outperform |
| May 7, 2020 | Mizuho | Maintained | — | Buy |
| May 7, 2020 | SunTrust Robinson Humphrey | Maintained | — | Buy |
| May 7, 2020 | HC Wainwright & Co. | Maintained | — | Buy |
| Apr 30, 2020 | Needham | Maintained | — | Buy |
| Apr 13, 2020 | Mizuho | Maintained | — | Buy |
| Apr 13, 2020 | Oppenheimer | Maintained | — | Outperform |
| Apr 1, 2020 | Stifel | Maintained | — | Buy |
| Mar 23, 2020 | B of A Securities | Maintained | — | Neutral |
| Feb 21, 2020 | H.C. Wainwright | Maintained | — | Buy |
| Nov 7, 2019 | Piper Jaffray | Maintained | — | Overweight |
| Nov 7, 2019 | Stifel Nicolaus | Maintained | — | Buy |
| Nov 7, 2019 | Cantor Fitzgerald | Maintained | — | Overweight |
| Aug 8, 2019 | JMP Securities | Reiterated | — | Market Outperform |
| Aug 8, 2019 | Cantor Fitzgerald | Reiterated | — | Overweight |